Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jan 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5289748013 | Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5289749017 | Acetaminophen 500 mg and guaifenesin 100 mg and phenylephrine (as phenylephrine hydrochloride) 5 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5289750017 | Guaifenesin 100 mg and paracetamol 500 mg and phenylephrine (as phenylephrine hydrochloride) 5 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Expectorant therapeutic role | false | Inferred relationship | Some | ||
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Phenylephrine hydrochloride (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Phenylephrine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute specifies the numerator unit for the presentation strength of a product. | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute specifies the denominator unit for the presentation strength of a product. | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Paracetamol | true | Inferred relationship | Some | 2 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Paracetamol | true | Inferred relationship | Some | 2 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute specifies the numerator unit for the presentation strength of a product. | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute specifies the denominator unit for the presentation strength of a product. | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Guaifenesin | true | Inferred relationship | Some | 3 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Guaifenesin | true | Inferred relationship | Some | 3 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute specifies the numerator unit for the presentation strength of a product. | mg | true | Inferred relationship | Some | 3 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | This attribute specifies the denominator unit for the presentation strength of a product. | Capsule (unit of presentation) | true | Inferred relationship | Some | 3 | |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Guaifenesin and paracetamol and phenylephrine only product in oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets